Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) announced today that it will…
Royalty Pharma Declares Second Quarter 2024 Dividend NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX)…